Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study.
Neurotherapeutics
; 18(2): 1316-1324, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33791970
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Schizophrenia
/
Antipsychotic Agents
/
Oxidative Stress
/
Risperidone
/
Antioxidants
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Neurotherapeutics
Journal subject:
NEUROLOGIA
Year:
2021
Document type:
Article
Affiliation country:
China
Country of publication:
United States